Rosalind Watts, PhD, is a clinical psychologist and the clinical lead of the psilocybin for depression trial at Imperial College London. She focuses on the themes of connectedness and acceptance over avoidance of difficult emotions as an important aspect of psychedelic treatment.
“Psilocybin for Depression: Introducing the ACE Model (Accept, Connect, Embody)” This presentation introduces the new therapeutic approach used in the ongoing Psilocybin for Depression study (Psilodep 2) at Imperial College.
This presentation outlines the therapy model currently used in the Imperial College London Psilocybin for Depression Study. The development and ongoing use of the ‘ACE’ (Accept, Connect, Embody) model will be described, including case material.